| |
Placebo (n = 166)
|
Grass AIT (n = 163)
|
|---|
|
Female, no. (%)
|
88 (53%)
|
88 (54%)
|
|
Race, no. (%)
| | |
|
White
|
134 (81%)
|
134 (82%)
|
|
Black
|
21 (13%)
|
21 (13%)
|
|
Hispanic/Latino
|
6 (4%)
|
4 (2%)
|
|
Non-smoker
|
121 (73%)
|
128 (79%)
|
|
Previous smoker, no. (%)
|
24 (14%)
|
26 (16%)
|
|
Smoker, no. (%)
|
21 (13%)
|
9 (6%)
|
|
Age, y
| | |
|
Mean (SD)
|
35.9 (11.7)
|
35.9 (11.7)
|
|
Range
|
18-62
|
18-65
|
|
Subjects with asthma, no. (%)
|
43 (26%)
|
46 (28%)
|
|
Sensitive to non-grass allergens per skin prick, no. (%)
| | |
|
White oak
|
74 (45%)
|
75 (46%)
|
|
White birch
|
84 (51%)
|
87 (53%)
|
|
Animal hair/dander (cat)
|
77 (46%)
|
79 (48%)
|
|
House dust mite
|
86 (52%)
|
93 (57%)
|
|
Mean duration of pre-treatment (weeks), [range]
|
16.2 [5.9, 23.9]
|
16.3 [6.4, 23.7]
|
- AIT Allergy immunotherapy tablet, DSS Daily symptom score, SD Standard deviation.
